Pfizer and BioNTech’s updated COVID-19 vaccine targeting the KP.2 strain, a descendant of JN.1, has been recommended by the ...

Wherever you sit in the partnership triangle, does it sound familiar? Many initiatives have tried to address this partnership ...

Picture this: a medicine targeting a particular disease is developed over 12-15 years from initial candidate selection, ...

Sanofi has shared positive results from a late-stage study of its investigational BTK inhibitor, tolebrutinib, in patients ...

The European Commission (EC) has extended the marketing authorisation for Bavarian Nordic’s smallpox and mpox vaccine to ...

Wedgewood Communications has appointed Danielle Cranwell as president and global agency head to lead the evolution of the agency’s strategic vision and future direction. Cranwell brings more than two ...

It was very disconcerting. For a fraction of a second, as I sat in a plush, modern boardroom, there across the table from me sat a magnificent giraffe, slowly ruminating as its small horns and large ...

Novo Nordisk and NanoVation Therapeutics have entered into a multi-year partnership worth $600m to advance genetic medicines ...

Merck & Co – known as MSD outside the US and Canada – and Daiichi Sankyo have announced that a late-stage trial of patritumab deruxtecan in non-small cell lung cancer (NSCLC) met its primary endpoint ...

Researchers from the Institute of Cancer Research (ICR) have found that prostate cancer patients with high levels of a specific protein have significantly poorer outcomes compared to those without.

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was awarded at a ...